InnerOptic — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

InnerOptic is a private, revenue-generating company specializing in 3D visualization and navigation software for image-guided medical procedures. Its core technology platform, centered around the FDA-cleared Aim™ software, is licensed and integrated into the products of major medical device partners like Medtronic, Acessa Health, and Francis Medical. The company leverages over 15 patents and a strong academic foundation to address the growing market for safer, simpler, and more effective minimally invasive interventions across oncology, urology, and interventional radiology.

OncologyUrologyWomen's Health

Technology Platform

Patented FDA-cleared software platform for 3D stereoscopic needle navigation using intraoperative ultrasound, with extensions into augmented reality (AR) and CT-Ultrasound image fusion.

Opportunities

The global shift towards minimally invasive procedures creates a large, growing demand for technologies that improve accuracy and safety.

InnerOptic's capital-efficient licensing model allows it to scale rapidly through partnerships with large device companies in interventional oncology, urology, and beyond.

The development of next-gen AR and multi-modality fusion platforms could open new, high-value market segments.

Risk Factors

Revenue is highly dependent on the commercial success of a small number of integration partners.

The surgical navigation space is competitive, with large incumbents and startups potentially developing alternative or in-house solutions.

Regulatory pathways for new software applications and augmented reality devices can be lengthy and uncertain.

Competitive Landscape

InnerOptic competes in the surgical navigation and visualization software space. Direct competitors include other software-focused companies like EchoPixel and smaller startups, while indirect competitors are large medical device companies (e.g., Medtronic, Johnson & Johnson, Siemens Healthineers) that have internal navigation divisions or may acquire competing technologies. Its differentiation lies in its specific focus on intuitive, stereoscopic 3D guidance for ultrasound-based needle procedures and its pure-play software licensing model.

More companies in Digital Health & Biotech SaaS →More companies in United States →